WO2007060104A3 - Aerosolformulierung für die inhalation enthaltend ein anticholinergikum - Google Patents

Aerosolformulierung für die inhalation enthaltend ein anticholinergikum Download PDF

Info

Publication number
WO2007060104A3
WO2007060104A3 PCT/EP2006/068395 EP2006068395W WO2007060104A3 WO 2007060104 A3 WO2007060104 A3 WO 2007060104A3 EP 2006068395 W EP2006068395 W EP 2006068395W WO 2007060104 A3 WO2007060104 A3 WO 2007060104A3
Authority
WO
WIPO (PCT)
Prior art keywords
aerosol formulation
anticholinergic agent
inhalation containing
formula
inhalation
Prior art date
Application number
PCT/EP2006/068395
Other languages
English (en)
French (fr)
Other versions
WO2007060104A2 (de
Inventor
Friedrich Schmidt
Original Assignee
Boehringer Ingelheim Int
Boehringer Ingelheim Pharma
Friedrich Schmidt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Boehringer Ingelheim Pharma, Friedrich Schmidt filed Critical Boehringer Ingelheim Int
Priority to US12/094,215 priority Critical patent/US20090170839A1/en
Priority to CA002629070A priority patent/CA2629070A1/en
Priority to EP06819434A priority patent/EP1957042A2/de
Priority to JP2008541689A priority patent/JP2010509182A/ja
Publication of WO2007060104A2 publication Critical patent/WO2007060104A2/de
Publication of WO2007060104A3 publication Critical patent/WO2007060104A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Die vorliegende Erfindung betrifft spezifische treibgasfreie, wässerige Aerosolformulierungen enthaltend ein oder mehrere Anticholinergika der Formel (1) worin X- ein Anion bedeutet, und das Kation der Formel (1) in der Zubereitung in einer Konzentration von 830,22 bis 904,2 mg pro 100 ml Arzneimittelzubereitung enthalten ist.
PCT/EP2006/068395 2005-11-24 2006-11-13 Aerosolformulierung für die inhalation enthaltend ein anticholinergikum WO2007060104A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US12/094,215 US20090170839A1 (en) 2005-11-24 2006-11-13 Aerosol formulation for inhalation containing an anticholinergic agent
CA002629070A CA2629070A1 (en) 2005-11-24 2006-11-13 Aerosol formulation for inhalation containing an anticholinergic agent
EP06819434A EP1957042A2 (de) 2005-11-24 2006-11-13 Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
JP2008541689A JP2010509182A (ja) 2005-11-24 2006-11-13 抗コリン作用薬を含む吸入用エアロゾル製剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005055957.3 2005-11-24
DE102005055957A DE102005055957A1 (de) 2005-11-24 2005-11-24 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum

Publications (2)

Publication Number Publication Date
WO2007060104A2 WO2007060104A2 (de) 2007-05-31
WO2007060104A3 true WO2007060104A3 (de) 2007-08-16

Family

ID=37888061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/068395 WO2007060104A2 (de) 2005-11-24 2006-11-13 Aerosolformulierung für die inhalation enthaltend ein anticholinergikum

Country Status (6)

Country Link
US (1) US20090170839A1 (de)
EP (1) EP1957042A2 (de)
JP (1) JP2010509182A (de)
CA (1) CA2629070A1 (de)
DE (1) DE102005055957A1 (de)
WO (1) WO2007060104A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005055961A1 (de) * 2005-11-24 2007-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
EP2504051B1 (de) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064164A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (de) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Vernebler
EP2835146B1 (de) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Zerstäuber
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
EA032459B1 (ru) 2014-05-07 2019-05-31 Бёрингер Ингельхайм Интернациональ Гмбх Небулайзер
PL3139979T3 (pl) 2014-05-07 2023-12-27 Boehringer Ingelheim International Gmbh Jednostka, nebulizator i sposób

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032899A1 (de) * 2000-10-14 2002-04-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
WO2003087097A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
WO2004022052A1 (de) * 2002-08-14 2004-03-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die inhalation enthaltend ein anticholinergikum

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040166065A1 (en) * 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055960A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055961A1 (de) * 2005-11-24 2007-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002032899A1 (de) * 2000-10-14 2002-04-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
WO2003087097A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
WO2004022052A1 (de) * 2002-08-14 2004-03-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die inhalation enthaltend ein anticholinergikum

Also Published As

Publication number Publication date
DE102005055957A1 (de) 2007-07-12
JP2010509182A (ja) 2010-03-25
CA2629070A1 (en) 2007-05-31
WO2007060104A2 (de) 2007-05-31
EP1957042A2 (de) 2008-08-20
US20090170839A1 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
WO2007060104A3 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
WO2007060108A3 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
WO2007090822A3 (de) Pharmazeutische formulierung für aerosole mit zwei oder mehr wirkstoffen und mindestens einer oberflächenaktiven substanz
WO2003082853A8 (en) New compounds
TW200736223A (en) N-(pyridin-2-yl)-sulfonamide derivatives
WO2001085212A3 (en) Drug delivery systems for photodynamic therapy
HK1064295A1 (en) Medical aerosol formulations
RS20050074A (en) Aerosol formulation for inhalation containing an anticholinergic agent
WO2006118948A3 (en) Therapeutic compositions
WO2005030211A8 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
WO2002074247A8 (en) Pharmaceutical formulations for sustained release
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
WO2004033418A3 (en) Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
TNSN08102A1 (en) Solid formulation of fungicidal mixtures
WO2007021970A3 (en) Stable pharmaceutical formulations and methods of use thereof
WO2006072070A3 (en) Pharmaceutical formulations of gallium salts
WO2002048148A3 (en) Pyrazolopyridine derivatives
CA2452326A1 (en) Topical leave-on compositions containing selected pantothenic acid derivatives
WO2004026836A8 (en) 1-pyridin-4-yl-urea derivatives
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
WO2002070464A3 (en) Hydrazones and their therapeutic use
WO2006021401A3 (en) Bicylononene derivatives
WO2002000166A3 (en) New compounds useful as antibacterial agents
WO2003035080A3 (en) A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2629070

Country of ref document: CA

Ref document number: 2006819434

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008541689

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006819434

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12094215

Country of ref document: US